Dear Sir/Madam, Pursuant to Regulation 13(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find the attached certificate from the RTA for the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Prism Medico and Pharmacy Ltd has submitted its quarterly investor complaints report to BSE and MSE as required under SEBI's Listing Regulations. The report, certified by their registrar Purva Sharegistry (India) Pvt Ltd, covers the quarter ended 31 March 2026. The company had zero complaints pending at the start of the quarter, zero received during the quarter, zero disposed of, and zero remaining unresolved at the end. This is a routine compliance filing with no investor grievances to report.
This is a routine regulatory disclosure and has no material impact on the stock price or shareholders. A clean complaint record suggests smooth investor servicing and basic compliance health.